In 2017, more than 47 000 Americans died of opioid misuse and overdose.1 In response to this crisis, many states have signed into law new regulations regarding the prescribing of opioids for acute and chronic pain. Florida House Bill 21 (HB21),2 which went into effect on July 1, 2018, mandated the following changes (among others) to opioid prescribing: (1) a limit of a 3-day to 7-day supply of opioids for acute pain, (2) a prohibition of refills ordered with the initial opioid prescription for acute pain, and (3) a requirement that the prescribing physician or his or her delegate check Florida’s prescription drug–monitoring program prior to prescribing opioids. We sought to quantify the association of Florida HB21 with opioid prescribing for acute postoperative pain at our institution.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Porter SB, Glasgow AE, Yao X, Habermann EB. Association of Florida House Bill 21 With Postoperative Opioid Prescribing for Acute Pain at a Single Institution. JAMA Surg. 2020;155(3):263–264. doi:10.1001/jamasurg.2019.4913
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: